Drug Trial Radar · NCT03117569
Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients
Last checked: Nov 20, 2026Latest source record: Dec 11, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
380
Actual
Start
Aug 21, 2017
Primary completion
Dec 19, 2018
Study completion Dec 19, 2018
Sponsor
- Lead sponsor
- Kirby InstituteGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Apr 18, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to determine if treatment monitoring schedule for chronic HCV patients treated with glecaprevir (300mg)/pibrentasvir (120mg) can be simplified. Data has shown that direct acting antiviral (DAA) regimen of glecaprevir (300mg)/pibrentasvir (120mg), a protease inhibitor and NS5A inhibitor respectively , provides key features for HCV treatment simplification. Eligible participants (naïve pre-cirrhosis chronic HCV patients) will be randomized (1:2) to the standard or simplified monitoring arm and will receive treatment for 8 weeks. One post treatment visit will be conducted 12 weeks after the final dose of study medication to evaluate the proportion of patients with undetectable HCV RNA at this timepoint (SVR12).
Conditions
- Hepatitis C, Chronic
Interventions
glecaprevir (300mg)/pibrentasvir (120mg)Drug
glecaprevir (300mg)/pibrentasvir (120mg) for 8 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Undetectable HCV RNA (ITT Population)Time frame: 12 weeks post end of treatment (SVR12)
Locations
33 sites in 8 countries. Site status is shown where the registry gives one.
Beth Israel Deaconess Medical Center
Boston, Massachusetts
New York University Langone Medical Center
New York, New York
Duke University Medical Center
Durham, North Carolina
SSM Health Dean Medical Group
Madison, Wisconsin
East Sydney Doctors
Sydney, New South Wales, Australia
St Vincent's Hospital Sydney
Sydney, New South Wales, Australia
Holdsworth House Medical Practice
Sydney, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
St Vincent's Hospital Melbourne
Melbourne, Victoria, Australia
Lair Centre
Vancouver, British Columbia, Canada
(G.I.R.I.) GI Research Institute
Vancouver, British Columbia, Canada
William Osler Health System
Brampton, Ontario, Canada
St Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
Toronto General Hospital
Toronto, Ontario, Canada
McGill University Health Centre (MUHC)
Montreal, Quebec, Canada
CHU de Québec-Université Laval
Québec, Quebec, Canada
Hopital Henri Mondor
Créteil, France
Hopital Saint Joseph
Marseille, France
Hopital Saint Antoine
Paris, France
zibp - Zentrum für Infektiologie Berlin Prenzlauer Berg GmbH
Berlin, Germany
Center for HIV and Hepatogastroenterology
Düsseldorf, Germany
Hannover Medical School
Hanover, Germany
CIM-Centrum fuer Interdisziplinaere Medizin GmbH
Münster, Germany
Auckland City Hospital
Auckland, New Zealand
Calder Center
Auckland, New Zealand
Christchurch Hospital
Christchurch, New Zealand
Dunedin Hospital
Dunedin, New Zealand
Inselspital - Universitaetsspital Bern
Bern, Switzerland
University Hospital Zurich
Zurich, Switzerland
Barts Health
London, United Kingdom
King's College Hospital
London, United Kingdom
Imperial College Healthcare NHS Trust (St Mary's Hospital)
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.